Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Facey, Karen
Henshall, Chris
Sampietro-Colom, Laura
and
Thomas, Sarah
2015.
IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT.
International Journal of Technology Assessment in Health Care,
Vol. 31,
Issue. 4,
p.
201.
Magro, Lara
Arzenton, Elena
Moretti, Ugo
Sottosanti, Laura
Potenza, Simona
and
Leone, Roberto
2016.
Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.
Expert Opinion on Drug Safety,
Vol. 15,
Issue. sup2,
p.
69.
Faulkner, SD
Lee, M
Qin, D
Morrell, L
Xoxi, E
Sammarco, A
Cammarata, S
Russo, P
Pani, L
and
Barker, R
2016.
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.
Clinical Pharmacology & Therapeutics,
Vol. 100,
Issue. 6,
p.
730.
Garattini, Livio
and
Curto, Alessandro
2016.
Performance-Based Agreements in Italy: ‘Trendy Outcomes’ or Mere Illusions?.
PharmacoEconomics,
Vol. 34,
Issue. 10,
p.
967.
Husereau, Don
Henshall, Chris
Sampietro-Colom, Laura
and
Thomas, Sarah
2016.
CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?.
International Journal of Technology Assessment in Health Care,
Vol. 32,
Issue. 4,
p.
191.
Cavicchi, Caterina
and
Vagnoni, Emidia
2017.
Does intellectual capital promote the shift of healthcare organizations towards sustainable development? Evidence from Italy.
Journal of Cleaner Production,
Vol. 153,
Issue. ,
p.
275.
Braithwaite, Jeffrey
2017.
Health Systems Improvement Across the Globe.
p.
439.
Cavicchi, Caterina
and
Vagnoni, Emidia
2017.
Does intellectual capital promote the shift of healthcare organizations towards sustainable development? Evidence from Italy.
Journal of Cleaner Production,
Capozzi, Monica
De Divitiis, Chiara
Ottaiano, Alessandro
Teresa, Tramontano
Capuozzo, Maurizio
Maiolino, Piera
Botti, Gerardo
Tafuto, Salvatore
and
Avallone, Antonio
2018.
Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples.
Frontiers in Public Health,
Vol. 6,
Issue. ,
Morrell, Liz
Wordsworth, Sarah
Schuh, Anna
Middleton, Mark R.
Rees, Sian
and
Barker, Richard W.
2018.
Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.
BMC Health Services Research,
Vol. 18,
Issue. 1,
Piatkiewicz, Trevor Jozef
Traulsen, Janine Marie
and
Holm-Larsen, Tove
2018.
Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends.
PharmacoEconomics - Open,
Vol. 2,
Issue. 2,
p.
109.
Singh, Gurparkash
Schulthess, Duane
Hughes, Nigel
Vannieuwenhuyse, Bart
and
Kalra, Dipak
2018.
Real world big data for clinical research and drug development.
Drug Discovery Today,
Vol. 23,
Issue. 3,
p.
652.
Jørgensen, Jesper
Mungapen, Laura
and
Kefalas, Panos
2019.
Data collection infrastructure for patient outcomes in the UK – opportunities and challenges for cell and gene therapies launching.
Journal of Market Access & Health Policy,
Vol. 7,
Issue. 1,
p.
1573164.
Trifirò, Gianluca
Gini, Rosa
Barone-Adesi, Francesco
Beghi, Ettore
Cantarutti, Anna
Capuano, Annalisa
Carnovale, Carla
Clavenna, Antonio
Dellagiovanna, Mirosa
Ferrajolo, Carmen
Franchi, Matteo
Ingrasciotta, Ylenia
Kirchmayer, Ursula
Lapi, Francesco
Leone, Roberto
Leoni, Olivia
Lucenteforte, Ersilia
Moretti, Ugo
Mugelli, Alessandro
Naldi, Luigi
Poluzzi, Elisabetta
Rafaniello, Concita
Rea, Federico
Sultana, Janet
Tettamanti, Mauro
Traversa, Giuseppe
Vannacci, Alfredo
Mantovani, Lorenzo
and
Corrao, Giovanni
2019.
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?.
Drug Safety,
Vol. 42,
Issue. 3,
p.
347.
Rejon‐Parrilla, Juan Carlos
Jonsson, Pall
and
Bouvy, Jacoline C.
2019.
Key enablers and barriers to implementing adaptive pathways in the European setting.
British Journal of Clinical Pharmacology,
Vol. 85,
Issue. 7,
p.
1427.
Gorkavenko, F. V.
Omelyanovskiy, V. V.
Bezdenezhnykh, T. P.
and
Khachatryan, G. R.
2019.
Health technology assessment and reimbursement of pharmaceuticals in Italy.
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology,
Vol. 12,
Issue. 2,
p.
156.
Eriksson, Irene
von Euler, Mia
Malmström, Rickard E.
Godman, Brian
and
Wettermark, Björn
2019.
Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System.
Applied Health Economics and Health Policy,
Vol. 17,
Issue. 1,
p.
93.
Moseley, Jane
Vamvakas, Spiros
Berntgen, Michael
Cave, Alison
Kurz, Xavier
Arlett, Peter
Acha, Virginia
Bennett, Simon
Cohet, Catherine
Corriol‐Rohou, Solange
Du Four, Emma
Lamoril, Christelle
Langeneckert, Anja
Koban, Maren
Pasté, Muriel
Sandler, Susan
Van Baelen, Karin
Cangini, Agnese
García, Sonia
Obach, Mercè
Gimenez Garcia, Emmanuel
Varela Lema, Leonor
Jauhonen, Hanna‐Mari
Rannanheimo, Piia
Morrison, Deborah
Van De Casteele, Marc
Strömgren, Anna
Viberg, Anders
Makady, Amr
and
Guilhaume, Chantal
2020.
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
British Journal of Clinical Pharmacology,
Vol. 86,
Issue. 6,
p.
1034.
Roig Izquierdo, Marta
Prat Casanovas, Maria Alba
Gorgas Torner, Maria Queralt
and
Pontes García, Caridad
2020.
Registro de pacientes y tratamientos de medicamentos hospitalarios en Cataluña: 10 años de datos clínicos.
Medicina Clínica,
Vol. 154,
Issue. 5,
p.
185.
Jørgensen, Jesper
Hanna, Eve
and
Kefalas, Panos
2020.
Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries.
Journal of Market Access & Health Policy,
Vol. 8,
Issue. 1,
p.
1715536.